SCHEMBL21480710

SCHEMBL21480710

CCC(I)C(=O)CCCCCN1C(=O)CCC1=O

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ HPGD P15428 2/20 0.47
▸ HTT P42858 2/20 0.47
▸ ALDH1A1 P00352 4/20 0.43
▸ HSD17B10 Q99714 2/20 0.41
▸ TSHR P16473 1/20 0.41
▸ ALPL P05186 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ FAAH O00519 1/20 0.40
▸ MGLL Q99685 1/20 0.40
▸ GAA P10253 3/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ MAPT P10636 2/20 0.38
▸ LMNA P02545 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ PTGS1 P23219 4/20 0.35
▸ PTGS2 P35354 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23106667 0.83 SMN1; SMN2 (0.48) SMN1; SMN2HPGDHTTALDH1A1HSD17B10
SCHEMBL19038332 0.81 SMN1; SMN2 (0.51) SMN1; SMN2HPGDHTTALDH1A1HSD17B10
SCHEMBL19038333 0.79 SMN1; SMN2 (0.49) SMN1; SMN2HPGDHTTALDH1A1HSD17B10
SCHEMBL21322473 0.75 SMN1; SMN2 (0.55) SMN1; SMN2HPGDHTTALDH1A1HSD17B10
SCHEMBL16847757 0.75 SMN1; SMN2 (0.55) SMN1; SMN2HPGDHTTALDH1A1HSD17B10
SCHEMBL22461613 0.74 HTT (0.51) SMN1; SMN2HPGDHTTALDH1A1HSD17B10
SCHEMBL19038331 0.74 SMN1; SMN2 (0.43) SMN1; SMN2HPGDHTTALDH1A1HSD17B10
SCHEMBL5697933 0.73 PTGS1 (0.61) SMN1; SMN2HPGDHTTALDH1A1HSD17B10
SCHEMBL8763346 0.73 SMN1; SMN2 (0.53) SMN1; SMN2HPGDHTTALDH1A1HSD17B10
SCHEMBL23615406 0.73 SMN1; SMN2 (0.53) SMN1; SMN2HPGDHTTALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019197506-A9 AXL-SPECIFIC ANTIBODIES FOR CANCER TREATMENT GENMAB A/S (DK) 2019-12-05 — — WO disclosed
WO-2019197506-A1 AXL-SPECIFIC ANTIBODIES FOR CANCER TREATMENT GENMAB A/S (DK) 2019-10-17 — — WO disclosed
Send feedback